Diagnostic uncertainty in the era of biosimilar natalizumab-The case for harmonizing anti-JCV antibody testing

Research output: Contribution to journalEditorial (Lead article)Contributedpeer-review

Contributors

Details

Original languageEnglish
Pages (from-to)751-753
Number of pages3
JournalMultiple Sclerosis Journal
Volume31
Issue number7
Publication statusPublished - 14 Jun 2025
Peer-reviewedYes

External IDs

ORCID /0000-0001-8799-8202/work/186184157
Scopus 105008079391

Keywords